Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biora Therapeutics, Inc. - Common Stock
(NQ:
BIOR
)
0.6061
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.6061
Bid (Size)
0.6150 (598)
Ask (Size)
0.6495 (40)
Prev. Close
0.6061
Today's Range
0.6061 - 0.6061
52wk Range
0.5850 - 6.700
Shares Outstanding
4,063,081
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Thursday's After-Market Session
April 18, 2024
Via
Benzinga
Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology
April 08, 2024
Claims cover key jet parameters for liquid jet delivery of a drug to the gastrointestinal tract
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
-54.43%
-54.43%
1 Month
-50.32%
-50.32%
3 Month
-32.26%
-32.26%
6 Month
-75.16%
-75.16%
1 Year
-76.04%
-76.04%
More News
Read More
Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development
April 04, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics: Q4 Earnings Insights
March 26, 2024
Via
Benzinga
Earnings Outlook For Biora Therapeutics
March 25, 2024
Via
Benzinga
Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 03, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 01, 2024
Via
Benzinga
Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 01, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 27, 2024
Via
Benzinga
BIOR Stock Earnings: Biora Therapeutics Misses EPS for Q4 2023
March 26, 2024
Via
InvestorPlace
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
March 26, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 26, 2024
March 26, 2024
Via
Benzinga
Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
March 18, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset
March 11, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 27, 2024
Via
Benzinga
Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600
February 26, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 27, 2024
Via
Benzinga
Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium
February 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
February 05, 2024
Via
Benzinga
Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.
January 22, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
January 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 17, 2024
Via
Benzinga
Biora Therapeutics Provides Outlook for 2024
January 16, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600
January 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.